Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 4, 2023, the Board of Directors (the "Board") of Pediatrix Medical Group, Inc., a Florida corporation (the "Company"), increased the size of the Company's Board to nine (9) members and appointed Ms. Sylvia Young to serve as a Director of the Company, each effective as of May 12, 2023. No arrangements or understandings exist between Ms. Young and any other person pursuant to which Ms. Young was appointed as a Director. Ms. Young has not yet been named to any committees of the Board.

Upon her appointment, Ms. Young will receive the standard compensation received by the Company's non-employee directors for service on the Board and committees thereof, described in the section entitled "Director Compensation" in the Company's Definitive Proxy Statement filed with the Securities and Exchange Commission (the "SEC") on March 31, 2023. In addition, Ms. Young will enter into an Indemnification Agreement with the Company, on substantially the terms contained in the Company's standard form previously filed with the SEC, which provides for indemnification of the indemnitee to the fullest extent allowed by Florida law.

Other than as described in this Current Report on Form 8-K, since the beginning of the Company's last fiscal year, the Company has not engaged in any transactions, and there are no proposed transactions, or series of similar transactions, in which the Company was or is to be a participant and in which Ms. Young had a direct or indirect material interest in which the amount involved exceeds or exceeded $120,000.

Item 7.01 Regulation FD Disclosure.

On May 4, 2023, the Company issued a press release announcing the appointment of Ms. Young. A copy of the press release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference. The information contained in this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" with the SEC nor incorporated by reference in any registration statement or other document filed by the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.


                                 Exhibit Index
Exhibit No.   Description

  99.1          Press Release of Pediatrix Medical Group, Inc. dated May 4,
              2023.
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses